Moment-to-moment control of blood pressure is important in the management of the neurosurgical patient. The ideal agent to control blood pressure or induce hypotension should be non-toxic, maintain cerebrovascular autoregulation, and not alter cardiac output or change intracranial pressure. Intravenous nitroglycerin has been used to control blood pressure in 54 neurosurgicai cases. This agent produces a rapid, controllable, but not precipitous fall in blood pressure without rebound, is non-toxic, may not alter cerebrovascular autoregulation, and does not raise intracranial pressure. Our clinical experience with intravenous nitroglycerin indicates that it has an important role as a hypotensive agent for the neurosurgical patient.
C
ONTROLLED hypotension during neurosurgery can aid in the reduction of morbidity and mortality by reducing the probability of hemorrhage and facilitating the surgical procedure) ,27,5~ The neurosurgical rationale of controlled hypotension also includes the maintenance of normotension after hemorrhage from an aneurysm or arteriovenous malformation until definitive neurosurgical intervention, and preservation of normotension postoperatively when hypertension would be deleterious? 7 The concept of hypotension as an adjunct to neurosurgery was first proposed by Harvey Cushing in 1917. TM He observed that hemorrhage was followed by vasoconstriction and that this led to a dry operating field. Subsequent to this, others 4,1~ had attempted to induce hypotension through arteriotomy. This technique has been abandoned because "controlled shock" affects far more than blood pressure (namely, the pumping ability of the heart, peripheral vascular resistance, microcirculatory mechanisms, blood volume regulation, blood rheology, and coagulability) 52 and produces tissue hypoxia) ~ Therefore, other methods have been employed to induce controlled hypotension. The production of vasomotor paralysis by blocking preganglionic sympathetic fibers through the use of subarachnoid drugs was reported in 1948. 25 This technique is not without hazard, e is timeconsuming, and is difficult to control. The selection of high spinal anesthesia merely to produce hypotension has been questioned. 37 Another method of decreasing peripheral resistance and inducing hypotension is the use of ganglionic blockade. Enderby TM was the first to use this method, and since then it has found wide popularity.
Trimethaphan is probably the most common ganglionic blocking agent in use today. It has the advantage of rapid action, probably due to its destruction by pseudocholinesterase? 2 This agent has certain side effects, including tachycardia, tachyphylaxis, inactivation of the pupillary reflex, curare-like action, and histamine release. The latter has the potential of increasing intracranial pressure directly by cerebral vasodilation or indirectly by inducing bronchospasm and raising arterial carbon dioxide pressure (PaCO2). Recent investigators have shown that trimethaphan is as deleterious to cerebral metabolism as is oligemia. ~ Deep halothane anesthesia will also produce hypotension primarily by direct myocardial depression with a subsequent fall in cardiac output? 6 This agent has also been shown to produce a loss of autoregulation, a4," to increase intracranial pressure (ICP), a~,47 to enhance cerebral edema following experimental lesions of the cerebral cortex, 48 and to produce cerebral lactic acidosis at concentrations above 2.3% even in the face of adequate oxygenation. '~ Other pharmacological agents that have been employed to decrease peripheral resistance include those that depress the midbrain autonomic centers (hydralazine) ~ and the medullary vasomotor centers (narcotics, hypnotics); those that stimulate the midbrain vasodilator centers (veratrum alkaloids); those that block the post-ganglionic sympathetic fibers (chlorpromazine, guanethidine, phentolamine); and those that have a direct effect on the vessel wallsY a The newest drug with action on the latter pharmacological target (vessel walls) is sodium nitroprusside (SNP).
Sodium nitroprusside is considered by many to be the agent of choice for induction of controlled hypotension because of its ability to easily affect blood pressure from moment to moment, and its apparent lack of tachyphylaxis. ~'51 However, one must be cognizant of its potential harmful effects when considering its use in the neurosurgical patient. The chemical structure of SNP (Fig.  1) Because of the potential advantages of this drug to the neurosurgical patient, we undertook the use of this drug for the induction of intraoperative controlled hypotension during neurosurgery.
Clinical Materials and Methods
Intravenous nitroglycerin was used to control blood pressure during elective neurosurgical procedures for aneurysm clipping, microdecompression of cranial nerves in the posterior fossa, and intracranial tumors.
A 0.4 mg/ml solution of nitroglycerin was prepared by aseptically dissolving 275 nitroglycerin tablets, 0.4 mg each, in 250 ml of normal saline solution and passing this through a 0.22-~z millipore filter into a sterile empty viaflex bag. The prepared solution was protected from light and used within 8 hours of preparation.
Preoperatively, all patients received intramuscularly 0.1 mg/kg of droperidol, 0.1 mg/ kg of morphine sulfate, and either 0.2 mg or 0.3 mg of glycopyrrolate approximately 45 minutes before arriving in the operating suite. Prior to the induction of anesthesia, an indwelling radial artery catheter was placed (providing the ulnar artery can provide adequate collateral flow to the thenar area when the radial artery is compressed) in order to monitor blood pressure and to facilitate sampling of arterial blood gases. All patients, regardless of position, were monitored for air embolization by the use of the Roche Embosonde Doppler,* with the cloverleaf Doppler probe and a right atrial catheter of which the position was verified by radiography. The position of the Doppler probe was further defined by the characteristic sound heard following a rapid injection of 10 ml of normal *Embosonde Model 2002 Doppler manufactured by Roche Medical Electronics Co., Cranbury, New Jersey. saline through the right atrial catheter. Additional patient monitors included an indwelling Foley catheter for urine measurement, an esophageal temperature probe, a peripheral nerve stimulator, and an electrocardiogram (Vs lead).
The anesthetic technique consisted of thiamylal sodium, pancuronium bromide, fentanyl, nitrous oxide, and oxygen. Anesthesia was induced with thiamylal sodium, and endotracheal intubation was undertaken following loss of twitch after 0.15 mg/kg of pancuronium and hyperventilation with oxygen (FiO2 = 1). Ventilation was controlled in all patients with a volume ventilator to maintain a PaCO2 of approximately 30 torr and an arterial oxygen pressure (PaO~) of greater than 100 torr.
At the time of induction 1 gm/kg mannitol was given to improve operating conditions. Controlled hypotension was induced with the prepared solution of nitroglycerin via an infusion pump in order to achieve a mean arterial blood pressure (MAP) approaching but not lower than 50 tort for aneurysm clipping, or to maintain an MAP to facilitate surgical manipulation for the other operative procedures, but not exceeding 80 to 90 torr nor lower than 50 torr.
After the definitive surgical manipulations, the patient's MAP was allowed to rise to one approaching but not exceeding 150 torr by adjusting the nitroglycerin infusion. Extrinsic pharmacological blood-pressure control was terminated before the completion of the operation in all patients except those requiring nitroglycerin in order to maintain an MAP lower than 150 torr.
The patients were all extubated in a responsive condition in the operating theater, and their blood pressures, electrocardiograms, and ventilatory and neurological status were monitored for at least 3 hours in the recovery room. From the recovery room the patients were transported to the neurosurgical intensive care unit for further observation.
Summary of Cases

Mean Arterial Pressure to Normotensive Levels
The MAP was lowered an average of 34.6% in this group following the intravenous administration of nitroglycerin (Tables 1 and 2 ). In Cases 20 and 24 there was an unintentional lowering of the MAP to hypotensive levels. The normotension was achieved in 90 seconds following the administration of nitroglycerin and maintained for up to 4 hours in some cases. The maximum dose of nitroglyceri n used was 4 mg. After the drug was discontinued, the MAP rose to values slightly below preinduction levels. There were no cases of postinfusion rebound.
Mean Arterial Pressure to Hypotensive Levels
The MAP fell an average of 47.4% from pre-nitroglycerin values (awake pre-anesthetic induction values) ( Table 2 ). Cases 1, 2, and 3 were considered failures because we were unable to achieve an MAP low enough to facilitate clipping of the aneurysm with nitroglycerin alone. Different adjuvants were tried in each case. The patient in Case 1 achieved an MAP of 90 torr after 30 mg of intravenous nitroglycerin. With the nitroglycerin still infusing, increments of 2.5 mg of chlorpromazine were administered intravenously to a total of 10 nag. The MAP fell to 50 torr and returned to 100 torr following cessation of the nitroglycerin. Case 2 required 1 mg of intravenous propranolol to bring the MAP from the nitroglycerininduced value of 80 torr to the surgically required value of 50 torr. The adjuvant drug used in Case 3 was SNP. The dose of SNP required to lower the MAP to an acceptable level was 0.25 mg/kg/min (about one-half of the lowest recommended dose).
Heart Rate
The heart rate did not increase significantly in either hypotensive or normotensive groups or when both groups were taken together.
Discussion
The results of our clinical evaluation of intravenous nitroglycerin indicate that it should be considered as the agent of choice for the production of controlled hypotension during neurosurgery.
Nitroglycerin produces a rapid but not precipitous fall in blood pressure when given intravenously and a rapid return to more "normal" pressures in the hypertensive patient following discontinuance of the drug. One of the advantages of nitroglycerin we observed is its apparent ability to lower blood pressure without the production of wide swings in blood pressure as seen with SNP. This finding becomes important in the light of work done by Ivankovich, et al. 2' They warned against sudden fluctuations in arterial blood pressure during hypotension induced by SNP since their study indicates that SNP abolishes autoregulation. Brown, et al.? found that in normal conscious human beings, nitroprusside impairs cerebral autoregulation. The flow data from this study indicate that cerebral vessels may not act like extracerebral vessels when exposed to intravenous nitroprusside, and that the ratio of extracranial blood flow may be altered so as to reduce the percentage of the cardiac output going to the cerebral circulation?
In our study, nitroglycerin was usually administered after the dura was opened. Direct observation of the brain parenchyma and vascular supply at the surgical site did not reveal either bulging or vascular engorgement following the initiation of nitroglycerininduced hypotension.
Nitroglycerin does not raise heart rate significantly and, as our data show, may even induce a relative bradycardia. The mechan-ism for this is unclear, but possibilities have been suggested. One proposal is a vagusmediated sympathoinhibitory reflex first proposed by Costantin n and recently mentioned by Come and Pitt? ~ Nitroglycerin is not a histamine-producer as is trimethaphan. This makes glyceryl trinitrate (GTN) the first choice as a hypotensive agent in patients with asthma or chronic pulmonary disease.
As previously mentioned, oligemia has been discarded as a means of controlled hypotension. Recently, Michenfelder and Theye 42 concluded that trimethaphan may be equated with hemorrhage as the least desirable method by which to produce hypotension. 42 There have been no reported cases of toxicity from the intravenous use of nitroglycerin, or from its use as a sublingual or topical agent. This apparent lack of toxicity is in contradistinction to a number of reported cases of toxicity from SNP. s,ga2 Recent work 42 has shown that when considering the overall cerebral effects of oligemia, halothane, trimethaphan, and SNP to produce hypotension, SNP had the most deleterious effects. The study concludes that this result is due to a direct toxic effect of nitroprusside over and above the effects of hypotension. 42 The action of nitroglycerin has been thought to be that of indiscriminate smoothmuscle relaxation. It has been reported, however, that nitroglycerin has a more pronounced effect on the capacitance vessels than on the resistance vessels? 8a9 Indeed, it has been shown that nitroglycerin can constrict certain vascular beds? Recent work by Cyong, et al., is demonstrates that nitroglycerin dilates the pulmonary capacitance vessels, thereby enlarging the large pulmonary reservoir and decreasing preload and lowering blood pressure.
Work by Gonzalez-Abola and coworkers 22 demonstrates that when GTN is given to normal control dogs, there is a slight rise in ICP, which quickly returns to preinfusion levels. However, when GTN is administered to dogs with a mass lesion (epidural balloon) there is no rise in ICP. This paradox can be explained by the fact, as already mentioned, that GTN acts on the capacitance vessels. Increased cerebral blood flow induced by GTN (increased ICP in normal dogs, headache following sublingual nitroglycerin in humans) is produced by venous dilatation without effecting arteriolar response? 8 The failure to induce increased ICP in dogs with mass lesions could have been due to the pressure applied by the epidural cerebral circulation while allowing the arterial side to remain unaffected.
If this hypothesis holds true, then patients who suffer from increased ICP due to mass lesions will benefit from dilating only their capacitance vessels (1 ~ pulmonary) thereby lowering ICP and reducing the rate of formation of brain edema? * This gives nitroglycerin a definite advantage over SNP, which acts primarily on resistance vessels, and has been shown to produce an increase in ICP and a loss of autoregulation? ,~8,8~.s2,5' This selective action of nitroglycerin for the capacitance side of the circulation could also prove protective during neurosurgical procedures when fixed retractors are used. Albin, et al., 2 have shown that excessive retraction pressure during hypotension with conventional agents can produce regional ischemia under the retractors. Since most hypotensive agents alter autoregulation and therefore the elasticity of the cerebral vasculature, and since most hypotensive agents affect either the resistance vessels or the entire circulatory system, the arteriolar resistance to external compression is compromised? e Nitroglycerin's unique action on the vascular system may help to prevent this compromise.
The use of nitroglycerin in the setting of the intensive care unit is appealing for a number of reasons. The etiology of neurogenic pulmonary edema is thought to be due to spasm of the small pulmonary venules. 4s,*s Nitroglycerin, because of its action on pulmonary capacitance vasculature, 7 might prove important in the treatment of these conditions. Nitroglycerin is devoid of toxic effects and produces a smooth and easily controlled lowering of blood pressure. This makes it useful in the long-term management of ICP and neurogenic pulmonary edema.
Conclusions
Parenteral nitroglycerin appears to be a useful agent in controlling blood pressure during neurosurgical procedures. It is relatively nontoxic, easily controlled, seems to plateau at the lowest arterial pressure acceptable for the individual patient, does not appear to alter cerebral autoregulation, and may have a protective effect on the heart to ischemia or hypoxia.
